Abstract
Several 'lines of therapy' that utilize cytotoxic agents and are driven by platinum-free intervals are the current standard of care for patients with recurrent ovarian cancer. For patients with platinum-resistant disease, single agent chemotherapy (pegylated liposomal doxorubicin, topotecan, gemcitabine or weekly paclitaxel) is the standard of care. For patients with platinum-sensitive disease, combination chemotherapy (carboplatin plus paclitaxel, pegylated liposomal doxorubicin or gemcitabine) is the standard of care. In addition, antiangiogenic therapy using bevacizumab is an established option. Future directions could include 'lines of therapy' with biologic agents driven by specific biologic targets. Data from antiangiogenic agents (trebananib, pazopanib and cediranib), antifolate drugs (farletuzumab and vintafolide), poly(ADP-ribose) polymerase inhibitors (olaparib and veliparib), mTOR inhibitors (everolimus and temsirolimus) and immune editing agents (nivolumab) have been summarized in this review.
References
Mar 11, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MarkmanJ L Lewis
Jun 27, 2003·Lancet·M K B ParmarUNKNOWN ICON and AGO Collaborators
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jacobus PfistererUNKNOWN EORTC GCG
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David G MutchAngeles Alvarez Secord
Mar 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gunter von MinckwitzSibylle Loibl
May 19, 2009·Gynecologic Oncology·Werner MeierJacobus Pfisterer
Jun 12, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I VergoteUNKNOWN ASSIST-1 Study Group
Sep 22, 2009·Lancet·Noriyuki KatsumataUNKNOWN Japanese Gynecologic Oncology Group
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Pujade-LauraineAndreas du Bois
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkAndrés M Poveda
Jul 21, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A PovedaB J Monk
Feb 3, 2011·JAMA : the Journal of the American Medical Association·Vishal RanpuraShenhong Wu
May 13, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A LortholaryUNKNOWN GINECO group France
Dec 30, 2011·The New England Journal of Medicine·Robert A BurgerUNKNOWN Gynecologic Oncology Group
Dec 30, 2011·The New England Journal of Medicine·Timothy J PerrenUNKNOWN ICON7 Investigators
Mar 29, 2012·The New England Journal of Medicine·Jonathan LedermannUrsula Matulonis
Apr 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carol AghajanianLawrence R Nycum
Aug 23, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L C HankerUNKNOWN AGO and GINECO study group
Nov 22, 2012·The Lancet Oncology·Jaafar BennounaUNKNOWN ML18147 Study Investigators
Oct 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R Wendel NaumannRichard A Messmann
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Pujade-LauraineIsabelle Ray-Coquard
Jun 22, 2014·The Lancet Oncology·Bradley J MonkAmit M Oza
Citations
Mar 6, 2016·Life Sciences·Barbara BukowskaAgnieszka Marczak
May 18, 2016·Journal of Ovarian Research·Åsa FranssonNina Mohell
Apr 20, 2017·The Journal of Obstetrics and Gynaecology Research·Tatsuya IshiguroTakayuki Enomoto
Jul 12, 2018·Cancer Chemotherapy and Pharmacology·Shravanti BhowmikThennati Rajamannar
Jul 28, 2019·Cancers·Laurie G HudsonAngela Wandinger-Ness
Jul 1, 2017·Cancer Science·Tadaaki NishikawaKeiichi Fujiwara
Jan 10, 2018·Investigational New Drugs·Diane A J van der BiessenCarla M L van Herpen
Aug 14, 2018·Pharmacological Reports : PR·Daohua ShiJintuo Zhou
Mar 18, 2016·Molecular Medicine Reports·Min Kyoung KimSeong-Gyu Ko
Nov 17, 2020·International Journal of Cancer. Journal International Du Cancer·Roy KessousWalter H Gotlieb
Sep 1, 2018·Pharmacological Reports : PR·Daohua ShiJintuo Zhou